Murphy Nicole bought BIIB
April 1, 2024 · Form 4 insider transaction
Murphy Nicole bought 240 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
240
Price
$0.00
Total value
N/A
InsiderMurphy Nicole
Role—
CompanyBiogen Inc. (BIIB)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2024
Filing dateApril 3, 2024
Shares owned after9,751
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024.